Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study

Huguet, JM; Garcia-Lorenzo, V; Marti, L; Paredes, JM; Ramirez, JJ; Pastor, M; Ruiz, L; Sanahuja, A; Timoneda, P; Sanchis, L; Perez, GA; Bosca-Watts, MM

Huguet, JM (通讯作者),Hosp Gen Univ Valencia, Gastroenterol Dept, Valencia 46014, Spain.

BIOMEDICINES, 2022; 10 (9):

Abstract

Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is characterized by chronic relapsing intestinal infla......

Full Text Link